التفاصيل البيبلوغرافية
العنوان: |
Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy |
المؤلفون: |
Hironori Kawamoto, M.D., Jin Takasaki, Satoru Ishii, Manabu Suzuki, Eriko Morino, Go Naka, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Haruhito Sugiyama |
المصدر: |
Respiratory Medicine Case Reports, Vol 21, Iss C, Pp 147-150 (2017) |
بيانات النشر: |
Elsevier, 2017. |
سنة النشر: |
2017 |
المجموعة: |
LCC:Diseases of the respiratory system |
مصطلحات موضوعية: |
Tuberculosis, Biological agent, Abatacept, Paradoxical reaction, Rheumatoid arthritis, Diseases of the respiratory system, RC705-779 |
الوصف: |
This case report describes the re-administration of abatacept to successfully reduce the articularsymptoms of a patient with rheumatoid arthritisduring the intensive phase of anti-tuberculous therapy. A 75-year-old man developed active pulmonary tuberculosis during the administration of abatacept for rheumatoid arthritis. The patient experienced a paradoxical reaction and exacerbation of rheumatoid arthritis that caused us to discontinue the abatacept. Later re-administration of abatacept along with anti-tuberculosis treatment led to well-controlled rheumatoid arthritis without exacerbation of the tuberculosis. This case shows that re-administration of abatacept may be much safer than TNF inhibitor to treat patients who are infected with mycobacteria during thetreatment of immunological diseases such asrheumatoid arthritiswith biological agents. |
نوع الوثيقة: |
article |
وصف الملف: |
electronic resource |
اللغة: |
English |
تدمد: |
2213-0071 |
Relation: |
http://www.sciencedirect.com/science/article/pii/S2213007117300631; https://doaj.org/toc/2213-0071 |
DOI: |
10.1016/j.rmcr.2017.04.013 |
URL الوصول: |
https://doaj.org/article/2782924252f84758b38339fe7eb8f052 |
رقم الانضمام: |
edsdoj.2782924252f84758b38339fe7eb8f052 |
قاعدة البيانات: |
Directory of Open Access Journals |